Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.
Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Sue Yom, explained in plain language.
This phase II trial tested whether adding the immunotherapy drug nivolumab (Opdivo) to standard chemoradiation helps treat stage II-IVB nasopharyngeal carcinoma, a type of throat cancer. Forty patients received nivolumab infusions every two weeks alongside cisplatin chemotherapy …
Phase 2 • Sponsor: Sue Yom • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC